Your browser version may not work well with NCBI's Web applications. More information here...
1: Arch Pediatr Adolesc Med. 2006 Nov;160(11):1121-5.Click here to read Links
Comment in:
Arch Pediatr Adolesc Med. 2006 Nov;160(11):1126-9.
Arch Pediatr Adolesc Med. 2007 May;161(5):518-9.
J Fam Pract. 2007 Feb;56(2):97.
J Pediatr. 2007 May;150(5):563-4.

Efficacy of duct tape vs placebo in the treatment of verruca vulgaris (warts) in primary school children.

Departments of General Practice and Dermatology, Maastricht University, 6200 MD Maastricht, the Netherlands.

OBJECTIVE: To determine the efficacy of duct tape compared with placebo in the treatment of verruca vulgaris. DESIGN AND SETTING: A randomized placebo-controlled trial in 3 primary schools in Maastricht, the Netherlands. PARTICIPANTS: One hundred three children aged 4 to 12 years with verruca vulgaris. INTERVENTIONS: Duct tape applied to the wart or placebo, a corn pad (protection ring for clavi), applied around the wart for 1 night a week. Both treatments were applied for a period of 6 weeks. Patients were blinded to the hypothesis of the study. MAIN OUTCOME MEASUREMENT: Complete resolution of the treated wart. RESULTS: After 6 weeks, the wart had disappeared in 16% of the children in the duct tape group compared with 6% in the placebo group (P = .12). The estimated effect of duct tape compared with placebo on diameter reduction of the treated wart was 1.0 mm (P = .02, 95% confidence interval, -1.7 to -0.1). After 6 weeks, in 7 children (21%) in the duct tape group, a surrounding wart had disappeared compared with 9 children (27%) in the placebo group (P = .79). Fifteen percent of the children in the duct tape group reported adverse effects such as erythema, eczema, and wounds compared with 0 in the placebo group (P = .14). CONCLUSION: In a 6-week trial, duct tape had a modest but nonsignificant effect on wart resolution and diameter reduction when compared with placebo in a cohort of primary school children.

PMID: 17088514 [PubMed - indexed for MEDLINE]